Meredith P. Young

• Represented clients in FINRA investigations, including a major financial institution in a matter involving alleged research report disclosure requirement violations.
• Defended healthcare systems in qui tam actions alleging various False Claims Act violations, including improper inpatient admissions, up-coding, and kickbacks.
• Represented Big Four accounting firms in connection with DOJ and SEC investigations related to the financial reporting of the firms' audit clients.
• Defended Equifax in connection with its 2017 data breach, including related regulatory investigations, enforcement actions, and congressional inquiries.
• Defended CVS Health in various enforcement matters involving the Controlled Substances Act and related federal and state regulations.
• Represented Allergan, Inc. in a False Claims Act case alleging the off-label promotion of Botox Therapeutic.

Meredith Young focuses on defending clients in government enforcement actions and False Claims Act cases, and conducting internal investigations. She has significant experience handling issues related to healthcare enforcement matters, securities enforcement actions - including accounting investigations, the Foreign Corrupt Practices Act, and controlled substance and pharmacy regulations. She has also represented clients in connection with banking industry and financial regulations.